Symposium 19: Secretagogues: sulfonylureas and incretins
Symposium 19: Drug Treatment: What's New? Secretagogues: sulfonylureas and incretins Both SUs and iDPP4 have earned a spot within current Diabetes (DM) therapy. Regarding SUs, we refer to glimepiride, gliclazide and glipizide. Since glimepiride has lately been advised against, we will leave i...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
Sello Editorial Lugones
2020-11-01
|
| Series: | Revista de la Sociedad Argentina de Diabetes |
| Subjects: | |
| Online Access: | https://revistasad.com/index.php/diabetes/article/view/353 |